Stockreport

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF The CALINA study tested a new ratio and dose of Coartem ® (artemether- lumefantrine) to account for metabolic differences in babies under 5 kg The CALINA trial indica [Read more]